Tuesday, Jun 28, 2022
Outlook.com

Omicron Subvariants Escape Neutralise Immunity Induced By Vaccination, Previous Infection: Study

Omicron Subvariants Escape Neutralise Immunity Induced By Vaccination, Previous Infection: Study

Omicron subvariants including BA.2.12.1, BA.4, and BA.5 substantially escape neutralising antibodies induced by both vaccination and previous infection, the study published in the New England Journal of Medicine has revealed.

24 June 2022
Hypertension Most Common Co-Morbidity: Delhi Hospital Study On Covid Patients

Hypertension Most Common Co-Morbidity: Delhi Hospital Study On Covid Patients

Doctors at a Delhi government-run hospital have conducted a study to examine the epidemiological characteristics of the pandemic and found that hypertension...

25 May 2022

Women With 'Long COVID' Have More Symptoms Than Men: Study

Long-COVID-syndrome is defined as persistent symptoms extending beyond 12 weeks after the initial symptoms of acute infection.

India Logs 2,075 Fresh COVID-19 Cases, 71 Deaths

India Logs 2,075 Fresh COVID-19 Cases, 71 Deaths

India's COVID-19 tally increased to 4,30,06,080 on Saturday with 2,075 fresh infections, while the active cases declined further to 27,802, according to Union...

19 March 2022

Over 3,900 Children In 12-14 Age Group Given Covid Jab In Delhi

Over 3,900 children aged between 12 and 14 were vaccinated against COVID-19 in Delhi on Thursday.

Advertisement
17 March 2022
Transmission Of COVID-19 Infection From Mother To Baby Rare: BMJ Study

Transmission Of COVID-19 Infection From Mother To Baby Rare: BMJ Study

The researchers found that less than two per cent of babies born to mothers with SARS-CoV-2 infection also test positive for the virus.


02 March 2022
Indian Researchers Create Math Model To Predict Covid-Vaccine Efficacy

Indian Researchers Create Math Model To Predict Covid-Vaccine Efficacy

Researchers at IISc and Australia's Queensland Brain Institute (QBI) in Australia have developed a mathematical model that predicts how antibodies generated by...


16 February 2022
Quality of antibodies improves for months after COVID-19 vaccination: Study

Quality of antibodies improves for months after COVID-19 vaccination: Study

The researchers at Washington University School of Medicine in the US assessed the antibody response to the Pfizer-BioTech vaccine in detail in people.


24 December 2021
How Safe Is It To Send Children To School Amid Omicron Scare?

How Safe Is It To Send Children To School Amid Omicron Scare?

While most parents and kids are happy with the schools reopening after a long break since March 2020, few parents are still highly apprehensive in sending...


30 November 2021
Study Says People With A, B Blood Groups, Rh+ More Susceptible To Covid

Study Says People With A, B Blood Groups, Rh+ More Susceptible To Covid

The researchers have also claimed that “there is no association between blood groups, and susceptibility to severity of disease as well as mortality”.


Advertisement

11 August 2021
Covid Delta Plus Variant Did Not Cause Exponential Surge In India Govt

Covid Delta Plus Variant Did Not Cause Exponential Surge In India Govt

Four types of variants are categorised as Delta Plus AY1 (B.1.617.2.1), AY2, AY3 and one more sub-lineage in which one more gene has been detected and its...


06 August 2021
Seven Months Post Infection, SARS-CoV-2 Antibody Immunoglobulin G Either Remains Stable Or Increases: Study

Seven Months Post Infection, SARS-CoV-2 Antibody Immunoglobulin G Either Remains Stable Or Increases: Study

The scientists noted that in order to predict the pandemic's evolution and develop effective strategies, it is critical to better understand the dynamics and...


06 August 2021
Drug Used To Reduce Blood Fat Is Capable Of Cutting Down SARS-CoV-2 Infection By 70 Per Cent: Study

Drug Used To Reduce Blood Fat Is Capable Of Cutting Down SARS-CoV-2 Infection By 70 Per Cent: Study

The reduction of infection was obtained using concentrations of the drug which are safe and achievable using the standard clinical dose of fenofibrate, the...


29 July 2021
Researchers Develop Variants Of More Potent, Stable Nanobodies To Fight SARS-CoV-2

Researchers Develop Variants Of More Potent, Stable Nanobodies To Fight SARS-CoV-2

Since nanobodies can be produced at low costs in large quantities, they could meet the global demand for COVID-19 therapeutics.


03 July 2021
Phase Three Clinical Trial Concludes 77.8 Per Cent Effectiveness Of Covaxin

Phase Three Clinical Trial Concludes 77.8 Per Cent Effectiveness Of Covaxin

The report suggests that the vaccine is capable of providing 65.2 percent protection from the lethal Delta Plus strain of Coronavirus and 93.4 per cent...


25 June 2021
First Covid-19 Case Could Have Emerged in China in October 2019, Reveals Study

First Covid-19 Case Could Have Emerged in China in October 2019, Reveals Study

The analysis suggests that the first case occurred in China between early October and mid-November of 2019.


Advertisement
Advertisement
Advertisement
Advertisement
Advertisement